Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) shares rose 0.1% during trading on Tuesday . The company traded as high as $0.3367 and last traded at $0.3073. Approximately 1,210,134 shares changed hands during trading, a decline of 25% from the average daily volume of 1,618,328 shares. The stock had previously closed at $0.3069.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Cosmos Health currently has a consensus rating of “Sell”.
Cosmos Health Stock Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. XTX Topco Ltd grew its stake in shares of Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Cosmos Health by 16.7% in the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after purchasing an additional 55,925 shares in the last quarter. Finally, Citadel Advisors LLC grew its stake in shares of Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares in the last quarter. Institutional investors own 12.61% of the company’s stock.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
Featured Stories
- Five stocks we like better than Cosmos Health
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
